Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults

DOI Full Paper Access

30

Citations

27

References

2022

Year

María Eugenia Toledo-Romaní, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, Suzel Pérez-Rodríguez, Meybis Rodriguez-González, Carmen Valenzuela‐Silva, Beatriz Paredes-Moreno, Belinda Sánchez-Ramírez, Raúl González-Mugica, Tays Hernández-García,

VaccinationVaccine SafetySoberana Plus VaccinesVaccine DevelopmentAnti-sars-cov-2 Heterologous SchemeVaccine EfficacyMedicineSoberana 02Covid-19

References

	Year	Citations

Page 1

Page 1